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a b s t r a c t
Hepatitis C virus (HCV) is a considerable global health and economic burden. The HCV nonstructural
protein (NS) 5A is essential for the viral life cycle. The ability of NS5A to interact with different host and
viral proteins allow it to manipulate cellular pathways and regulate viral processes, including RNA
replication and virus particle assembly. As part of a proteomic screen, we identiﬁed several NS5A-
binding proteins, including the lysine methyltransferase SET and MYND domain containing protein 3
(SMYD3). We conﬁrmed the interaction in the context of viral replication by co-immunoprecipitation
and co-localization studies. Mutational analyses revealed that the MYND-domain of SMYD3 and domain
III of NS5A are required for the interaction. Overexpression of SMYD3 resulted in decreased intracellular
and extracellular virus titers, whilst viral RNA replication remained unchanged, suggesting that SMYD3
negatively affects HCV particle production in a NS5A-dependent manner.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Hepatitis C virus (HCV) is a positive-sense, single-stranded RNA
virus and among the leading causes of chronic hepatitis, a
condition often complicated by liver cirrhosis, steatosis and cancer.
With an estimated 170 million people persistently infected
worldwide, HCV constitutes a major global health and economic
burden (Davis et al., 2011; Mohd Hanaﬁah et al., 2013). The viral
genome consists of a single-strand RNA molecule of 9.6-kb,
encoding only a single polyprotein, which is processed into the
three structural proteins core, E1, E2, and the seven non-structural
(NS) proteins, p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B
(reviewed in (Bartenschlager et al., 2011)). NS5A is a multifunc-
tional, RNA-binding phosphoprotein with key functions in HCV
replication and assembly. In addition, NS5A manipulates various
cellular pathways to generate an intracellular environment favor-
ing viral replication (Cordek et al., 2011).
The protein is composed of three domains (DI, DII and DIII) that
are connected by trypsin-sensitive low complexity sequences (LCSI
and II) and contains an N-terminal amphipatic α-helix which
tethers NS5A to intracellular membranes (Brass et al., 2002; Penin
et al., 2004; Reiss et al., 2011; Tellinghuisen et al., 2004). DI and DII
are required for genome replication, whereas DIII is essential for
the generation of infectious virus particles (Appel et al., 2008;
Masaki et al., 2008; Tellinghuisen et al., 2008b). Thus far, no
enzymatic activity has been ascribed to NS5A and although it has
been subject to intensive research, the molecular events required
for the various effects of NS5A are far from being fully understood.
Nevertheless, differential interactions with host as well as viral
proteins seem to form the basis of NS5A function (Cordek et al.,
2011).
As part of a large-scale proteomic survey of virus–host protein
interactions, we identiﬁed several cellular binding partners of
NS5A (genotype 1b) using a tandem-afﬁnity puriﬁcation (TAP)
mass spectrometry (MS) approach (Pichlmair et al., 2012).
Included among the highest ranking proteins was the SET and
MYND domain containing protein 3 (SMYD3). SMYD3 is a lysine
methyltransferase (KMT) which catalyzes di- and trimethylation of
histones H3 and H4, implicating it in transcriptional regulation
(Cock-Rada et al., 2012; Foreman et al., 2011; Hamamoto et al.,
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2004). In addition, SMYD3 has also been shown to methylate the
vascular endothelial growth factor receptor 1 (VEGFR1) and
enhance its kinase activity (Kunizaki et al., 2007). However, there
are no reports regarding a role of SMYD3 in the HCV life cycle.
Results and discussion
To follow up and expand on the initial NS5A screen results
(Pichlmair et al., 2012), the original samples were re-analyzed on a
hybrid linear trap quadrupole (LTQ) Orbitrap Velos. We identiﬁed a
total of 274 proteins, compared to the 50 detected in the ﬁrst
analysis. A caveat of improved sensitivity is the higher detection
rate of non-speciﬁc binding proteins. In order to ﬁlter false-
positive interactors more efﬁciently, we included additional nega-
tive controls available from the recently published CRAPome
repository (www.crapome.org) in our analysis. All identiﬁed pro-
tein interactions were scored using spectral counts to calculate
both the SAINT probability and fold change (FC_B) score (Choi
et al., 2011; Mellacheruvu et al., 2013). A SAINT probabilityZ0.9
and an FC_B scoreZ4 was used as threshold to enrich for high
conﬁdence interactors, leaving a total of 24 proteins (Fig. 1A), 50%
of which overlapped with our previously published data set
(supplemental table 1). In addition, 15 from the 24 were either
already validated as NS5A-binding partners or have been con-
ﬁrmed in a study published during the preparation of this manu-
script by Germain et al., using a similar experimental approach
(supplemental table 1) (Germain et al., 2014).
In addition to the previously characterized NS5A-binding
proteins Ubiquitin Speciﬁc Peptidase 19 (USP19) and Amphiphysin
II (BIN1), one of the highest ranking proteins was the KMT SMYD3
(Masumi et al., 2005; Pichlmair et al., 2012; Zech et al., 2003). This
ﬁnding is consistent with two previous studies, that further
corroborated our results (de Chassey et al., 2008; Germain et al.,
2014). Since none of these studies had conﬁrmed the SMYD3–
NS5A interaction, we veriﬁed it by employing Myc-tagged NS5A
and HA-tagged SMYD3 that were co-expressed in HEK 293T cells
and subjected to co-immunoprecipitation (co-IP) assays. As shown
in Fig. 1B, SMYD3 co-puriﬁed with immunoprecipitated NS5A and
vice versa when the reciprocal co-IP was performed. The catalytic
activity of SMYD3 was not relevant for the association, since NS5A
interacted just as strongly with a point mutant of SMYD3 (Y239F)
previously described to be catalytically inactive (Foreman et al.,
2011; Xu et al., 2011). Finally, we conﬁrmed the interaction
of endogenous SMYD3 with TAP-tagged NS5A expressed in
doxycyline-regulated HEK Flp-In cells (Fig. 1D) (Pichlmair et al.,
2012).
To further characterize the interaction, we aimed to map the
region in SMYD3 bound by NS5A. SMYD3 is a two-lobed protein:
the N-terminal region harbors the catalytic SET-domain, which is
split by a MYND-domain, a zinc-ﬁnger motif mediating protein–
protein and protein–DNA interactions (Hamamoto et al., 2004).
The C-terminal lobe consists of three tetratricopeptide repeat
motifs and is proposed to have a regulatory role in SMYD3 activity
by blocking the substrate binding site. Based on the crystal
structure of SMYD3, internal deletion mutants were cloned. These
lacked surface exposed areas or regions lining the catalytic site
(Fig. 2A) (Foreman et al., 2011; Sirinupong et al., 2010; Xu et al.,
2011). Although none of the mutants resulted in a complete loss of
NS5A-binding, the deletion of the MYND-domain (mutant SΔ2)
severely impaired the interaction. The mutant SΔ3 lacking the
adjacent residues 88–124 also exhibited reduced binding to NS5A,
suggesting that the MYND-domain is either improperly folded in
this mutant, or that the binding region extends into the SET-
domain (Figs. 2B and C). In addition SMYD3 SΔ2 failed to co-
localize with Myc-NS5A when co-transfected in Hela cells
(Supplemental Fig. 1).
Next, we investigated which region of NS5A interacted with
SMYD3. Of note, attempts to co-precipitate SMYD3 with immu-
nopuriﬁed NS5A using a monoclonal mouse anti-NS5A antibody
(9E10) failed, suggesting antibody binding may overlap with the
SMYD3 binding site (data not shown). Since the antibody detects
an epitope in DIII, we generated NS5A mutants lacking parts of the
C-terminal portion of the protein (Fig. 2D). As shown in Fig. 2E
and F, deleting residues encompassing DII had no effect on
the interaction with SMYD3, whereas the absence of residues
Fig. 1. Identiﬁcation and conﬁrmation of SMYD3 as interactor of NS5A. (A) Schematic representation of NS5A-binding proteins identiﬁed by TAP-MS with an FC_B scoreZ4.
Node color gradient corresponds to increasing log2 FC_B scores. Known interactions are depicted by black edges, novel interactions by gray edges. NS5A is highlighted in
blue. Two biological replicates were analyzed as technical duplicates. (B) Interaction of overexpressed SMYD3 and NS5A. Myc-NS5A, HA-SMYD3 or catalytic inactive SMYD3
(Y239F) were transiently expressed in HEK 293T cells. 48 h posttransfection, protein complexes were immunoprecipitated and analyzed by Western blot. Representative
blots of 3 independent experiments are shown. (C) Interaction of endogenous SMYD3 with TAP-tagged NS5A. Expression of NS5A in HEK FlpIn Strep-HA-NS5A cells was
induced by addition of 1 mg/ml doxycyline. After 48 h, NS5A was immunoprecipitated and samples analyzed by Western blot.
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343–448, which correspond to LCSII and DIII, abolished SMYD3
binding. The LCSII contains numerous prolines, a common recog-
nition motif of MYND-domains (Ansieau and Leutz, 2002). To
distinguish if either LCSII or DIII were responsible for the interac-
tion, we included an additional mutant lacking only DIII. The
presence, however, of the polyproline motif in LCSII did not restore
SMYD3 binding, meaning that the association is mediated by DIII.
Taken together, our results conﬁrm SMYD3 as speciﬁc binding
partner of NS5A and identify the SMYD3 MYND-domain and DIII
of NS5A as regions mediating the interaction.
To validate these results in a more authentic system we
evaluated if SMYD3 also interacted with NS5A in the context of
an active viral replicase. To this end, we generated Huh7.5 cells
stably expressing HA-tagged SMYD3 (Huh7.5/HA-SMYD3). Pre-
vious reports have shown that adding an N-terminal tag to SMYD3
does not interfere with its catalytic activity, nor does it seem to
alter its subcellular localization (Fig. 3E) (Foreman et al., 2011;
Hamamoto et al., 2004; Kunizaki et al., 2007). Huh7.5/HA-SMYD3
cells were then electroporated with RNA encoding the genotype 2a
subgenomic JFH1 replicon, or the full-length genome of the
chimeric strain termed Jc1, which produces high amounts of
infectious particles in culture (Pietschmann et al., 2006). In both
cases, NS5A co-precipitated with HA-SMYD3 (Fig. 3A and C). NS5A
exists in a basal and a hyperphosphorylated state. Based on
apparent molecular weight, these are commonly referred to as
p56 and p58, respectively (Tanji et al., 1995). Interestingly, we
found the p58 form preferentially co-precipitated with SMYD3
(Fig. 3B and D).
In addition, we used immunoﬂuorescence to examine the
localization of SMYD3 with subgenomic replicon-derived NS5A
Fig. 2. Mapping the binding sites of SMYD3 and NS5A. (A) Schematic representation of full-length SMYD3 and respective deletion mutants. The N-terminal lobe contains the
catalytic SET-domain (blue), which is split by the zinc-ﬁnger MYND-domain (red). The second lobe consists of regulatory C-terminal domain (purple). Residues spanning the
individual domains are indicated. (B) Association of Myc-tagged NS5Awith HA-tagged SMYD3 deletion mutants. The indicated plasmids were co-expressed in HEK 293T cells
and co-immunoprecipitation experiments were performed as in Fig. 1B. (C) Ratio of co-puriﬁed NS5A with the respective SMYD3 mutants. Bars represent the ratio of
quantiﬁed band signals of the Western blots shown above. (D) Schematic representation of full-length NS5A and respective deletion mutants. NS5A consists of 3 domains
(blue, red and purple, respectively) connected by two low-complexity sequences (black). Residues spanning the individual domains are indicated. (E) Association of
HA-tagged SMYD3 with Myc-tagged NS5A deletion mutants. The indicated plasmids were co-expressed in HEK 293T cells and co-immunoprecipitation experiments were
performed as in (B). (F) Ratio of co-puriﬁed SMYD3 with the respective NS5A mutants. Bars represent the ratio of quantiﬁed band signals of the Western blots shown above.
(B and E) Representative blots of at least 2 similar experiments are shown.
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in Huh7.5 cells. In accordance with previous studies, NS5A loca-
lized to cytoplasmic, most often perinuclear foci (Fig. 3E insets)
(Gosert et al., 2003). In some instances, NS5A staining appeared as
ring-like structures, probably corresponding to lipid droplets
decorated with this protein (Appel et al., 2008). As shown in
Fig. 3E, NS5A clearly co-localized with HA-tagged overexpressed as
well as endogenous SMYD3. The latter is of particular importance,
as attempts to detect an interaction between NS5A and endogen-
ous SMYD3 were not successful, due to the lack of a suitable anti-
SMYD3 antibody to immunoprecipitate the endogenous protein
(data not shown). Collectively, our data reveal that SMYD3 and
NS5A also interact and co-localize with each other in the context
Fig. 3. Interaction of SMYD3 with NS5A in the context of viral replication. (A and C) Huh7.5/HA-SMYD3 cells were electroporated with RNA encoding the JFH1 subgenomic
replicon (sgJFH1) or full-length Jc1. 72 h post electroporation, HA-SMYD3 was immunoprecipiated and analyzed by Western blot using anti-HA and anti-NS5A antibodies.
(B and D) Enrichment of hyperphosphorylated NS5A (p58) in SMYD3 pull-downs. Western blot bands shown in (A) and (C) corresponding to the p56 and p58 phosphoforms
of NS5A were quantiﬁed and the p58/P56 ratio calculated. (E) Co-localization of overexpressed HA-SMYD3 (top panel) or endogenous SMYD3 with subgenomic JFH1 NS5A.
Huh7.5 cells were electroporated as described above. After 48 h, cells were ﬁxed and proteins stained using SMYD3 (green) and NS5A (red) antibodies. Nuclei were
counterstained with DAPI. Images were analyzed by confocal microscopy. Co-localization was quantiﬁed using ImageJ and the WCIF ‘Intensity Correlation Analysis’ plugin
(upper panel: Rr¼0.746; R¼0.903; lower panel: Rr¼0.620; R¼0.781).
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of active viral replication. Furthermore, the fact that SMYD3
associates also with genotype 2a NS5A indicates that the interac-
tion is not genotype-speciﬁc.
SMYD3 is upregulated in various types of cancer, in particular
colon, breast, prostate and liver carcinomas, where it exhibits
potent growth promoting effects. Interestingly, RNAi-mediated
knockdown of SMYD3 has been shown to result in cell cycle arrest
and apoptosis of different cancer cell lines, including the human
hepatoma cell line Huh7, fromwhich Huh7.5 and Huh7-Lunet cells
used in this study are derived (Blight et al., 2002; Chen et al., 2007;
Friebe et al., 2005; Hamamoto et al., 2004; Ren et al., 2010). In
order to investigate if SMYD3 had a role in the HCV life cycle, but
at the same time avoid off-target effects due to RNAi-induced
cytotoxicity associated with SMYD3 knockdown, we generated a
Huh7-Lunet-derived cell pool stably overexpressing wildtype
SMYD3 (Lunet/S3) or the catalytically inactive point mutant
SMYD3 Y239F (Lunet/YF) (Fig. 4A) that was still capable of
interacting with NS5A (Fig. 1B).
First, we analyzed whether SMYD3 had an effect on viral RNA
replication kinetics. To this end, stable Huh7-Lunet/S3 or Lunet/YF
cells were electroporated with subgenomic JFH-1 reporter replicon
RNA and viral replication was quantiﬁed by measuring Fireﬂy lucifer-
ase activity in cell lysates harvested at several time points after
transfection. As shown in Fig. 4B, luciferase activities were similar
for each cell line, excluding a role of SMYD3 in viral replication. Similar
results were obtained for the full-length, infectious Renilla luciferase
reporter virus JcR2A (Fig. 4C) (Reiss et al., 2011). Next, we assessed if
SMYD3 inﬂuenced infectious virion production in the form of infec-
tious particles release relative to viral replication (Infectivity/replica-
tion). For this purpose we infected naïve Huh7.5 cells with
supernatants harvested from JcR2a-transfected Lunet/S3, Lunet/YF or
Lunet/GFP cells and quantiﬁed Renilla activity 48 h post infection.
Interestingly, relative infectivity of virus particles released from Lunet/
S3 cells was more than 3-fold lower as compared to GFP-control cells.
This effect appeared to be speciﬁc as it was not observed in cells
overexpressing catalytic inactive SMYD3 (Fig. 4D). To distinguish if this
defect occurred at the level of virus particle assembly or release, we
determined relative infectivity in cell culture supernatants and corre-
sponding cell lysates that were prepared by repeated cycles of freezing
and thawing (extra- and intracellular infectivity, respectively). Naive
Huh7.5 cells were inoculated with the respective fractions and
luciferase activity was determined 48 h later. As shown in Fig. 4E,
cells overexpressing wildtype SMYD3 exhibited a reduction of relative
intra- as well as extracellular infectivity amounts (5-fold and 2-fold,
respectively), whereas titers of Lunet/YF cells were similar to Lunet-
GFP cells, arguing that SMYD3 impaired infectious particle assembly.
To corroborate this observation, we repeated this experiment
by using a reporter-free virus genome and more direct assays. The
Fig. 4. SMYD3 is a negative regulator of HCV infectious particle assembly. (A) Western blot analysis of Huh7-Lunet cells stably expressing wildtype (WT) SMYD3, catalytic
inactive (Y239F) SMYD3 or GFP. (B) Effect of SMYD3 overexpression on HCV RNA replication kinetics. Indicated cell lines were electroporated with RNA encoding the
subgenomic JFH1 luciferase reporter replicon. Viral replication was measured at the indicated time points by luciferase assay. Luciferase activity is expressed in relative light
units (RLU) normalized to the 4 h value to account for different transfection efﬁciencies. (C) Effect of SMYD3 overexpression on replication of the full-length infectious Renilla
reporter virus JcR-2A. Indicated cell lines were electroporated with JcR-2A RNA and harvested after 4 and 48 h. Viral replicationwas quantiﬁed as mentioned above. (D) Effect
of SMYD3 overexpression on JcR-2A relative infectivity. Supernatants from (C) were harvested at the indicated time points and used to inoculate naïve Huh7.5 cells in
duplicate. 48 h post infection, Renilla activity in reinfected cells was measured as in (B) Viral infectivity is expressed as ratio of re-infection over replication. (E) JcR-2A intra-
and extracellular infectivity. Cells pellets and supernatants of cells transfected with JcR-2A RNA were subjected to 3 freeze-thaw cycles 48 h postelectroporation. Viral
infectivity in the respective fractions was determined as mentioned above. (F) Effect of SMYD3 overexpression on intra- and extracellular virus titers of the non-reporter
virus Jc1. The different Huh7-Lunet cell lines were transfected with Jc1 RNA. 48 h postelectroporation, cell pellets and supernatants were treated by freezing and thawing as
described above. Viral infectivity was determined by limiting dilution assay and data are represented as TCID50/ml. (G) Intra- and extracellular amounts of HCV core protein.
Core levels in cell lysates and corresponding supernatants were determined by core-speciﬁc ELISA 4 and 48 h postelectroporation of Jc1 RNA. Concentrations of core are
depicted as pg/ml normalized to intracellular core levels 4 h post electroporation to account for different transfection efﬁciencies. Bars represent mean values and standard
error of the means from 3 (JcR-2A) or 2 (sgJFH1 and Jc1) independent experiments.
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individual cell lines were electroporated with RNA encoding the
chimeric virus Jc1 and after 48 h intra- and extracellular virus
titers were quantiﬁed by limiting dilution assay (TCID50/ml)
(Fig. 4F) In addition, we determined concentrations of HCV core
protein in cell lysates and supernatants by core ELISA (Fig. 4F).In
accordance with our previous results, virus titers were 4 times
lower in Lunet/S3 cells, whereas overexpressing catalytically
inactive SMYD3 resulted in titers similar to GFP control cells
(Fig. 4F). Interestingly, the reduction in virus titers coincided with
an overall intracellular accumulation of core protein (Fig. 4G), with
levels detected in Lunet/S3 cells on average three times higher
compared to GFP control cells.
To exclude the possibility that SMYD3 overexpression inﬂu-
enced the cellular secretory capacity in general, we transfected the
different Huh7-Lunet cell lines with a plasmid encoding the
naturally secreted Gaussia luciferase (G-luc) and monitored G-luc
activity in the supernatants over time. Protein secretion was
almost identical among the different cell lines, indicating that
the reduction of virus titers in response to SMYD3 overexpression
was speciﬁc for HCV assembly and not the consequence of
impaired protein secretion (supplemental Fig. 2). Taken together,
our data suggest that SMYD3 negatively regulates virus particle
production by interfering with the assembly process of infectious
virions, which is reﬂected in form of reduced virus titers and an
overall accumulation of intracellular core protein.
As mentioned in the introduction, NS5A is a multitasking protein,
coordinating various stages of the viral life cycle, as well as interfering
with many different host cellular pathways. It is believed, that
different NS5A interactions with viral and cellular proteins, presum-
ably regulated by the NS5A phosphorylation state, determine its
functional state (Cordek et al., 2011; Huang et al., 2007). As shown
here and in earlier studies, one of these interaction partners is SMYD3.
To date, very little is known about its physiological role. Given that
lysine methylation is increasingly recognized as an important post-
translational modiﬁcation regulating protein function and ﬁne-tuning
many essential signaling pathways, one might speculate that SMYD3
is a component of one or more cellular processes that are involved in
virus production (Erce et al., 2012). Alternatively, SMYD3 might be
involved in the modiﬁcation and impairment of other HCV proteins
required for assembly. Binding to SMYD3 would therefore allow NS5A
to counteract SMYD3 function and ensure productive virion assembly.
This hypothesis is supported by the fact that NS5A interacted with
SMYD3 through DIII, the domain essential for virus formation (Appel
et al., 2008, 2005; Hughes et al., 2009; Tellinghuisen et al., 2008a).
Conclusion
In summary, we report the identiﬁcation of the lysine methyl
transferase SMYD3 as a binding partner of HCV NS5A. Using cell lines
overexpressing wildtype or non-functional SMYD3, we identiﬁed
SMYD3 as potential negative regulator of HCV infectious particle
assembly. Further studies, in particular regarding the cellular function
and targets of SMYD3, may aid to gain more mechanistic insight into
SMYD3-mediated assembly inhibition and help to decipher the still
only partially understood HCV assembly process.
Materials and methods
Liquid chromatography mass spectrometry and data validation
TAP-MS analyses of NS5A-associated protein complexes has
been performed as previously described (Pichlmair et al., 2012).
The same samples were re-analyzed by liquid chromatography
mass spectrometry (LCMS) on a hybrid linear trap quadrupole
(LTQ) Orbitrap Velos (ThermoFisher Scientiﬁc) coupled to an
Agilent 1200 series HPLC (Agilent technologies) as previously
described (Huber et al., 2014). The list of all identiﬁed proteins
was uploaded to the ‘Contaminant Repository for Afﬁnity
Puriﬁcation-Mass spectrometry data (CRAPome) repository’
(www.crapome.org) and ﬁltered against a set of 17 negative
control samples. Negative control samples were chosen according
to the following criteria: cell line (HEK 293), epitope tag (Strep-
HA), subcellular fraction (total cell lysate), instrument type (LTQ
Orbitrap Velos). Spectral count data was used to calculate the
‘Signiﬁcance Analysis of Interactome’ (SAINT) probability (low
mode¼0, min fold¼1, Normalize¼1) and a fold change score
(FC_B; default settings) (Choi et al., 2011; Mellacheruvu et al.,
2013). Both scoring tools are available on the repository website.
Proteins were ﬁrst ﬁltered based on a SAINT probabilityZ0.9,
followed by a second ﬁlter corresponding to a FC_B scoreZ4. The
NS5A interactome was visualized using cytoscape (www.cytos
cape.org).
Cell lines and cell culture
All cell lines were maintained in Dulbecco's Modiﬁed Eagle
Medium (Gibco) supplemented with 10% FCS (Invitrogen), 2 mM
Glutamine and antibiotics (100 U/ml penicillin and 100mg/ml strep-
tomycin). HEK FlpIn Strep-HA-NS5A cells have been described pre-
viously (Pichlmair et al., 2012).The human hepatoma cell line Huh7.5
was purchased from Apath LLC (St. Louis, MO). Huh7-Lunet cells have
been described previously (Friebe et al., 2005; Koutsoudakis et al.,
2006). Cells stably expressing SMYD3, SMYD3 Y239F, GFP or HA-
SMYD3 were generated by lentiviral transduction and selected and
maintained in DMEM containing 5 μg/ml of puromycin.
Plasmid constructs
Expression vectors encoding full-length or truncated proteins
were generated by Gateways recombination reactions (Invitro-
gen) as described previously (Pichlmair et al., 2012). Expression
vectors used in this study were: pcDNA-N-2HA-TEV-GW and
pCS2-N-6xMyc-GW for transient expression in HEK 293T cells
and pWPI-GW and pWPI-N-HA-GW for the generation of lentiviral
particles. Internal and point mutations were introduced by site-
directed mutagenesis (Agilent Technologies) of the respective
pDONR201 vectors according to the manufacturer's instructions.
All primer sequences used in this study are available upon request.
Plasmids pFK_i389LucNS3-30JFH_δg (sgJFH1), pFK-J6/Core-846/
JFH1_wt_δg (Jc1) and pFK_i389-JcR2a_δg_JC1 (JcR2a) encoding
the JFH1 subgenomic reporter replicon, the full-length chimeric
genome Jc1 and the Jc-1 derived reporter virus JcR-2A, respec-
tively, have been described recently (Kaul et al., 2007;
Pietschmann et al., 2006; Reiss et al., 2011).
Lentiviral gene transduction
Huh7-Lunet and Huh7.5 cells stably expressing SMYD3, SMYD3
Y239F, GFP or HA-SMYD3, respectively, were generated by lenti-
viral transduction. For lentivirus production, HEK 293T were
seeded in 6-well plates and co-transfected with the respective
lentiviral vector pWPI (1 mg), the packaging vector pCMVR8.91
(750 ng) and the envelope vector pMD.G (250 ng) using Lipofec-
tamine2000 (Invitrogen) as recommended by the manufacturer.
Target cells were seeded in a 6-well plate and infected with
ﬁltered viral supernatants harvested after 48 h. Transduced cells
were selected by addition of 5 mg/ml puromycin 24 h post infec-
tion. SMYD3 WT, SMYD3 Y239F or GFP expression was analyzed
by Western blot using rabbit anti-SMYD3 (Abcam, 1:2000) or
mouse anti-GFP (Roche, 1:5000) antibodies.
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Co-Immunoprecipiations
HEK 293T cells were co-transfected with the indicated plasmids
using Polyfect (QIAGEN) according to the manufacturer's protocol.
The amount of DNA per plasmid was adjusted to achieve equal
expression. Total levels of transfected DNA were kept constant by
the addition of empty vector. For co-precipitation of endogenous
SMYD3 with TAP-tagged NS5A: HEK FlpIn cells inducibly expres-
sing NS5A fused to a tandem Strep-tag II-hemagglutinin (Strep-HA
or TAP-tag) were cultured in the presence of 1 mg/ml doxycline.
48 h post transfection or doxycycline induction, cells were lysed in
IP-buffer (50 mM Tris/HCl pH 8.0, 150 mM NaCl, 1%NP40, 5 mM
EDTA, 5 mM EGTA, protease inhibitor cocktail (Roche), 50 mM NaF
and 1 mM Na3VO4) and cleared by centrifugation. 1.5 or 2 mg of
total protein was incubated with anti-HA, or anti-Myc agarose
beads (SIGMA) for 1.5 h at 4 1C. Beads were washed 3 with IP-
buffer and then eluted in 5% (v/v) SDS/PBS. Immunoprecipitates
were analyzed by Western blot using the tag-speciﬁc directly
conjugated antibodies rabbit anti-Myc IRDye™800 (Rockland) and
mouse anti HA7-HRP (SIGMA) as indicated. Endogenous SMYD3 in
HEK FlpIn cells was detected using rabbit anti-SMYD3 as men-
tioned above. NS5A expressed in the context of the subgenomic or
full-length replicons was detected using the monoclonal mouse
anti-NS5A 9E10 (1:10,000; kind gift from Prof. Charles Rice;
Rockefeller University, New York). Bands were quantiﬁed using
the ImageJ software (Schneider et al., 2012).
Confocal microscopy
Huh7.5 wildtype or Huh7.5/HA-SMYD3 cells electroporated
with subgenomic JFH1 replicon transcripts were grown on cover-
slips for 72 h. Cells were rinsed with PBS, ﬁxed with 4% parafor-
maldehyde for 15 min, and then permeabilized with 0.1% Triton X-
100 for 15 min. After rinsing with PBS, cells were blocked with 5%
goat serum (GS) for 1 h. Cells were stained with rabbit anti-SMYD3
(1:300; Abcam) and mouse anti-NS5A (1:1000; 9E10) diluted in 5%
GS for 1 h. After four washes with PBS, slips were incubated in the
dark with Alexa Fluor 488 anti-rabbit and 568 anti-mouse sec-
ondary antibodies (both 1:1000 in 5%GS; Molecular Probes) for
1 h. Nuclei were counterstained with DAPI. Cover slips were
mounted on glass slides using ProLong Gold Antifade reagent
(Invitrogen). Images were acquired using a Zeiss LSM 700 confocal
laser scanning microscope. Co-localization of ﬂuorescence signals
was evaluated quantitatively for Pearson's correlation coefﬁcient
(Rr) and Manders coefﬁcient (R) by using the ‘Image J’ software
and the ‘Intensity Correlation Analysis’ plugin.
RNA in vitro transcription and electroporation
in vitro transcription of MluI-linearized plasmids was per-
formed as described previously (Krieger et al., 2001). Brieﬂy,
5–10 μg of linearized plasmids were in vitro transcribed in an
overnight reaction using T7 RNA polymerase and terminated by
the addition of DNAse. RNA was extracted with acidic phenol and
chloroform, precipitated in isopropanol and the pellet dissolved in
H2O. RNA integrity was assessed by agarose gel electrophoresis.
For electroporation of in vitro transcribed RNA, 1107 cells/ml
of Huh7-Lunet cells were suspended in cytomix supplemented
with 2 mM ATP, pH 7.6 and 5 mM glutathione (van den Hoff et al.,
1990). 200 μl of cell suspension were mixed with 5 μg of RNA,
transferred to an electroporation cuvette (gap width of 0.2 cm)
and electroporated using the BioRad Gene Pulser System at 975 μF
and 166 V. Cells were immediately transferred to 13 ml of fresh
medium and seeded as described below. For co-precipitation
experiments, 1.5107 cells/ml of Huh7.5 or Huh7.5/HA-SMYD3
cells were suspended in cytomix as above. 400 ml of cell
suspension was mixed with 7.5 mg of RNA and electroporated in
cuvettes with a 0.4 gap width at 975 mF and 270 V. Cells were then
resuspended in 20 ml DMEM, transferred to 15 cm2 dishes and
incubated for 72 h.
Replication and infectivity assays
Quantiﬁcation of Fireﬂy or Renilla luciferase activity as readout
for sgJFH1 and JcR2A replication, respectively, was performed as
described previously (Reiss et al., 2011). Brieﬂy, cells were lysed in
300 ml (6-well plate) of lysis buffer at the indicated time points
post electroporation. Luminescence in 20 ml of lysate was quanti-
ﬁed in technical duplicates for 10 s in a luminometer (Lumat
LB9507; Berthold, Freiburg, Germany). Relative light units (RLUs)
were normalized to the respective 4 h value to account for
differences in transfection efﬁciency.
To measure JcR-2A infectivity, supernatants were collected 48 h
post electroporation and used to inoculate naïve Huh7.5 cells
seeded in 24-well plates the day before (5104 ml1). Renilla
activity was measured 48 h post reinfection as described above. Jc1
infectivity was determined by limiting dilution assay on Huh7.5
cells (Lindenbach et al., 2005). Positive cells were stained with a
mouse monoclonal NS3 (2E3) antibody and HRP-conjugated anti-
mouse polyclonal antibody (Sigma) (Backes et al., 2010). To measure
intra- and extracellular infectivity, electroporated (Jc1 or JcR-2A)
cells were seeded on 10 cm2 dishes. After 48 h, cells were harvested
and subjected to multiple freeze-thaw cycles as described pre-
viously (Gastaminza et al., 2006). Viral titers of the respective
fractions were determined as described above.
Core ELISA
To quantify HCV core protein amounts, transfected cells were
seeded into 6-well plates (2 ml/well). After 48 h, cell culture
supernatants were ﬁltered through 45 mm ﬁlters and diluted 1:2
with PBS supplemented with 1% Triton X-100. To determine
intracellular core amounts, cell monolayers were washed twice
with PBS and lysed by addition of 0.5 ml PBS containing 0.5%
Triton X-100 and 1 mM PMSF, 0.1 mg/ml Aprotinin and 4 mg/ml
Leupeptin. Lysates were cleared by centrifugation at 10,000 RPM
for 10 min at 4 1C. HCV core protein was quantiﬁed in the Central
Laboratory of the University Hospital Heidelberg (Analysezentrum,
Heidelberg, Germany). If required, samples were diluted with PBS
containing 0.5% Triton X-100.
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